A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer

Journal of the National Cancer Institute

Volumn 88, Issue 15, 1996, Pages 1039-1045

  Gelber, Richard D ^a,b,h   Goldhirsch, Aron ^c   Cole, Bernard F ^d   Wieand, Harry S ^e   Schroeder, Georgene ^f   Krook, James E ^g  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Ospedale Civico Lugano   (Switzerland)

^d BROWN UNIVERSITY   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f N Ctrl Cancer Treatm Grp S   (United States)

^g Duluth Clinic   (United States)

^h DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; SEMUSTINE;

ALOPECIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; DIARRHEA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MAJOR CLINICAL STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; QUALITY OF LIFE; RADIATION DERMATITIS; RECTUM CANCER; SMALL INTESTINE OBSTRUCTION; STOMATITIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

EID: 0029779273     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.15.1039     Document Type: Article

References (24)

1. Prolongation of the disease-free interval in surgically treated rectal carcinoma. Gastrointestinal Tumor Study Group. N Engl J Med 1985;312: 1465-72.
2. Douglass HO Jr, Moertel CG, Thomas PR, Mayer RJ, Lindblad AS, Mittleman A, et al. Survival after postoperative combination treatment of rectal cancer [letter]. N Engl J Med 1986;315:1294-5.
3. Fisher B, Wolmark N, Rockette H, Redmond C, Deutsch M, Wickerham DL, et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01 [prior annotation incorrect]. J Natl Cancer Inst 1988;80:21-9.
4. Balslev I, Pedersen M, Teglbjaerg PS, Hanberg-Soerensen F, Bone J, Jacobsen NO, et al. Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid. A randomized multicenter study. Cancer 1986;58:22-8.
5. Rider WD, Palmer JA, Mahoney LJ, Robertson CT. Preoperative irradiation in operable cancer of the rectum: report of the Toronto trial. Can J Surg 1977;20:335-8.
6. Duncan W. Adjuvant radiotherapy in rectal cancer: the MRC trials. Br J Surg 1985;72:s59-s62.
7. Roswit B, Higgins GA, Keehn RJ. Preoperative irradiation for carcinoma of the rectum and rectosigmoid colon: report of a National Veterans Administration randomized study. Cancer 1975;35:1597-602.
8. Higgins GA, Humphrey EW, Dwight RW, Roswit B, Lee LE Jr, Keehn RJ. Preoperative radiation and surgery for cancer of the rectum. Veterans Administration Surgical Oncology Trial II. Cancer 1986;58:352-9.
9. Gerard A, Buyse M, Nordlinger B, Loygue J, Pene F, Kempf P, et al. Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg 1988;208:606-14.
10. Boulis-Wassif S, Gerard A, Loygue J, Camelot D, Buyse M, Duez N. Final results of a randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil, followed by radical surgery. Trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. Cancer 1984;53:1811-8.
11. Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Rectal Cancer Study Group. Cancer 1990;66:49-55.
12. Reis Neto JA, Quilici FA, Reis JA Jr. A comparison of nonoperative vs preoperative radiotherapy in rectal carcinoma. A 10-year randomized trial. Dis Colon Rectum 1989;32:702-10.
13. Horn A, Morild I, Dahl O. Tumour shrinkage and down staging after preoperative radiation of rectal adenocarcinomas. Radiother Oncol 1990; 18:19-28.
14. Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Bean RW, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma [see comment citations in Medline]. N Engl J Med 1991;324:709-15.
15. Gelber RD, Goldhirsch A. A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer. J Clin Oncol 1986;4:1772-9.
16. Goldhirsch A, Gelber RD, Simes RJ, Glasziou P, Coates AS. Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis. The Ludwig Breast Cancer Study Group [see comment citation in Medline]. J Clin Oncol 1989;7:36-44.
17. Glasziou PP, Simes RJ, Gelber RD. Quality adjusted survival analysis. Stat Med 1990;9:1259-76.
18. Gelber RD, Goldhirsch A, Cavalli F. Quality-of-life-adjusted evaluation of adjuvant therapies for operable breast cancer. The International Breast Cancer Study Group [see comment citation in Medline]. Ann Intern Med 1991;114:621-8.
19. Gelber RD, Cole BF, Gelber S, Goldhirsch A. Comparing treatments using quality-adjusted survival: the Q-TWiST method. Am Stat 1995;49:161-9.
20. Gelber RD, Lenderking WR, Cotton DJ, Cole BF, Fischl MA, Goldhirsch A, et al. Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. The AIDS Clinical Trials Group. Ann Intern Med 1992;116:961-6.
21. Lenderking WR, Gelber RD, Cotton DJ, Cole BF, Goldhirsch A, Volberding PA, et al. Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group [see comment citations in Medline]. N Engl J Med 1994;330:738-43.
22. Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. Gastrointestinal Tumor Study Group. J Clin Oncol 1992;10:549-57.
23. O'Connell M, Martenson J, Rich T, Wieand H, Krook J, Macdonald J, et al. Protracted venous infusion (PVI) 5-fluorouracil (5FU) as a component of effective combined modality postoperative surgical adjuvant therapy for high-risk rectal cancer. Proc ASCO 1993;12:193.
24. Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Reichman B, et al. Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach [see comment citation in Medline]. J Clin Oncol 1992;10:1218-24.